The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to determine whether the dual antiplatelet therapy (aspirin and
clopidogrel) for 3 months after coronary implantation of zotarolimus-eluting stent is safe in
terms of death, myocardial infarction, or stent thrombosis.